Vor Biopharma Inc [VOR] stock is trading at $34.69, up 10.90%. An important factor to consider is whether the stock is rising or falling in short-term value. The VOR shares have gain 14.11% over the last week, with a monthly amount drifted -15.80%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vor Biopharma Inc [NASDAQ: VOR] stock has seen the most recent analyst activity on September 24, 2025, when Stifel upgraded its rating to a Buy but kept the price target unchanged to $55 for it. Previously, H.C. Wainwright upgraded its rating to Buy on June 30, 2025, and kept the price target unchanged to $3. On July 26, 2022, Wedbush initiated with a Outperform rating and assigned a price target of $18 on the stock. Goldman started tracking the stock assigning a Neutral rating and suggested a price target of $6 on April 27, 2022. H.C. Wainwright initiated its recommendation with a Buy and recommended $26 as its price target on December 17, 2021. Robert W. Baird started tracking with a Outperform rating for this stock on December 03, 2021, and assigned it a price target of $38. In a note dated December 02, 2021, Oppenheimer initiated an Outperform rating and provided a target price of $30 on this stock.
Vor Biopharma Inc [VOR] stock has fluctuated between $2.62 and $65.80 over the past year. Currently, Wall Street analysts expect the stock to reach $29 within the next 12 months. Vor Biopharma Inc [NASDAQ: VOR] shares were valued at $34.69 at the most recent close of the market. An investor can expect a potential drop of -16.4% based on the average VOR price forecast.
Analyzing the VOR fundamentals
Gross Profit Margin for this corporation currently stands at -0.54% with Operating Profit Margin at -99.67%, Pretax Profit Margin comes in at -451.55%, and Net Profit Margin reading is -451.55%. To continue investigating profitability, this company’s Return on Assets is posted at -8.1, Equity is 5.24 and Total Capital is -2.51.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 32.04 points at the first support level, and at 29.38 for the second support level. However, for the 1st resistance point, the stock is sitting at 37.02, and for the 2nd resistance point, it is at 39.34.
Ratios To Look Out For
For context, Vor Biopharma Inc’s Current Ratio is 3.49. On the other hand, the Quick Ratio is 3.49, and the Cash Ratio is 3.24.
Transactions by insiders
Recent insider trading involved Reprogrammed Interchange LLC, 10% Owner, that happened on Sep 16 ’25 when 0.45 million shares were sold. 10% Owner, Reprogrammed Interchange LLC completed a deal on Sep 15 ’25 to sell 0.4 million shares. Meanwhile, 10% Owner Reprogrammed Interchange LLC sold 0.3 million shares on Sep 12 ’25.